All Articles

Orezone Gold’s first full quarter as a multi-mine producer shows strong growth, but a wildfire near its new Canadian asset tests its operational resilience.

A new Kelowna clinic's high-tech chair promises relief for a problem affecting millions. But its arrival reveals more about our healthcare system's gaps.

In a Texas suburb, a network of smart defibrillators and citizen volunteers beat EMS to a cardiac arrest scene. It’s a look at the future of emergency response.

As Olin and Huntsman clear a key SEC hurdle, the strategic rationale behind their merger comes into focus: a calculated move to build a resilient, vertically integrated powerhouse.

The pizza giant's new value menu isn't just about cheap eats. It's a masterclass in cultural strategy, blending nostalgia, streetwear, and digital bait.

A new alliance in Vancouver is tackling Canada's critical life sciences talent shortage, creating a model for integrating education and industry nationwide.

A new survey reveals most Canadians understand credit, yet nearly half can't improve their score, fueling a controversial market for alternative lenders.

Taiwan's LITEON is planting a $919M flag in Texas, a move that's more than just jobs. It's a strategic rewiring of supply chains to power the AI boom.

As Singapore rushes toward an electric future, a new challenge emerges. One firm is proving that education, not just inventory, is key to winning the used EV market.

A state-backed project revisits the Long March's pivotal moments in Gansu, framing revolutionary history as a tool for modern national rejuvenation and global soft power.

Atrium Therapeutics' clinical trial for a rare cardiomyopathy isn't just a milestone; it's a strategic maneuver signaling the arrival of precision RNA therapies in cardiology.

The payment giant says operations are normal and refuses to pay hackers. But with business data and transaction records stolen, what is the true cost of defiance?

SCRYPT's new stablecoin corridors in East Africa bypass dollar scarcity, positioning digital assets as vital infrastructure, not speculative bets.

As new FRS 102 rules overhaul UK lease accounting, Crunchafi's software launch signals a high-stakes battle for a market where spreadsheets no longer suffice.

Telana renews its exclusive Microsoft Azure Expert MSP status, validating its model for freeing UK firms from operational toil to drive tangible, AI-led growth.

For 18 years, WEI has dominated a key industry ranking. This isn't luck; it's a masterclass in strategic execution. Here's how they do it.

A national home improvement firm is ditching legacy data silos for a modern AI-ready foundation. It’s a move that reveals the real work behind AI's promise.

A new B2BINPAY update focuses on operational stability, not hype. These tedious but vital changes signal the maturation of crypto from asset to utility.

Elevara Medicines taps biotech veteran Dr. Mai-Britt Zocca to lead its charge against rheumatoid arthritis with a novel drug and $70M in backing.

A new watchdog emerges as millions use unapproved GLP-1 drugs, many believing they're FDA-approved. How a shortage solution became a risky shadow market.